Karen Harum
Neurodevelopmental Disabilities · Wilmington, NCNPI 1568423499
Payments from drug & device makers
Across 122 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- Supernus Pharmaceuticals, Inc.$723
- Ironshore Pharmaceuticals Inc.$548
- Neurelis, Inc.$380
- Collegium Pharmaceutical, Inc.$141
- Axsome Therapeutics, Inc.$122
- plus $937 from 17 others
What the payments were for
- Travel & lodging$68017%
- Food & beverage$3,36583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 2 | $1,193 |
| Supernus Pharmaceuticals, Inc. | 24 | $723 |
| Ironshore Pharmaceuticals Inc. | 27 | $548 |
| Neurelis, Inc. | 17 | $380 |
| Collegium Pharmaceutical, Inc. | 7 | $141 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Grifols USA, LLC | 5 | $112 |
| Baxter Healthcare | 4 | $103 |
| Tris Pharma Inc | 6 | $98 |
| CSL Behring | 6 | $95 |
| Advanced Respiratory, Inc | 3 | $88 |
| Corium, LLC | 4 | $87 |
| Jazz Pharmaceuticals Inc. | 2 | $58 |
| Biogen | 2 | $46 |
| Adlon Therapeutics L.p. | 2 | $41 |
| Acadia Pharmaceuticals Inc | 2 | $36 |
| Organon | 1 | $34 |
| Philips North America LLC | 2 | $33 |
| Photonicare Inc | 1 | $33 |
| Phadia US Inc. | 1 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,193
- Auvelity$122
How this compares
Too few neurodevelopmental disabilities providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 17 | $533 |
| Duloxetine Hcl | 15 | $316 |
| Atropine Sulfate | 12 | $295 |
| Spironolactone | 12 | $238 |
| Haloperidol | 15 | $232 |
| Levothyroxine Sodium | 29 | $229 |
| Lamotrigine | 28 | $208 |
| Clonidine Hcl | 21 | $109 |
| Clonazepam | 24 | $103 |
| Baclofen | 11 | $87 |
| Lithium Carbonate | 14 | $65 |
| Escitalopram Oxalate | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other neurodevelopmental disabilities in Wilmington
- Kristi MilowicRaleigh$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.